You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 2, January 24, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Stroke
 •Alert me on articles by topic

Prevalence of Abnormal Glucose Tolerance Following a Transient Ischemic Attack or Ischemic Stroke

Walter N. Kernan, MD; Catherine M. Viscoli, PhD; Silvio E. Inzucchi, MD; Lawrence M. Brass, MD; Dawn M. Bravata, MD; Gerald I. Shulman, MD, PhD; James C. McVeety, MD

Arch Intern Med. 2005;165:227-233.

Background  Despite current preventive therapies, patients with transient ischemic attack (TIA) and ischemic stroke remain at high risk for recurrent brain disease and cardiovascular events. In an effort to develop new therapies, abnormal glucose tolerance has recently been proposed as an interventional target. Among persons not otherwise known to be diabetic, impaired glucose tolerance (IGT) and diabetic glucose tolerance (DGT) are each associated with an increased risk for incident vascular disease, vascular disease mortality, and all-cause mortality. We conducted this study to determine if IGT and DGT are sufficiently common among patients with TIA and ischemic stroke to warrant therapeutic trials of antihyperglycemic agents.

Methods  Men and women older than 45 years were recruited from 3 hospitals in south central Connecticut. Eligibility criteria included a recent TIA or nondisabling ischemic stroke, no history of physician-diagnosed diabetes mellitus, and a fasting plasma glucose level less than 126 mg/dL (<7.0 mmol / L). After an overnight fast, subjects were admitted to a clinical research center for a standard 75-g oral glucose tolerance test. Impaired glucose tolerance was defined by a 2-hour plasma glucose value of 140 to 199 mg/dL (7.8-11.0 mmol / L) and DGT by a value of 200 mg/dL or greater (≥11.1 mmol/L).

Results  Between June 2000 and August 2003, we enrolled 98 eligible patients. The average time from TIA or stroke to measurement of glucose tolerance was 105 days (range, 24-180 days) and the median age was 71 years. Twenty-seven subjects (28%) had IGT and 24 (24%) had diabetes. In a forward stepwise logistic regression model, only a fasting plasma glucose level of 110 mg/dL or greater (≥6.1 mmol / L) and lower waist circumference were associated with an increased risk for IGT or DGT.

Conclusions  Impaired glucose tolerance and DGT are present in most persons with a recent TIA or ischemic stroke who have no history of diabetes and a fasting plasma glucose level less than 126 mg/dL (<7.0 mmol / L). Our findings bring new urgency to the initiation of research to examine the effectiveness of antihyperglycemic therapies among patients with cerebrovascular disease and abnormal glucose tolerance.


Author Affiliations: Departments of Internal Medicine (Drs Kernan, Viscoli, Inzucchi, Bravata, and Shulman), Neurology (Drs Brass and McVeety), Epidemiology and Public Health (Dr Brass), and Cellular & Molecular Physiology (Dr Shulman), Yale School of Medicine, New Haven, Conn; Veterans Affairs Connecticut Healthcare System, West Haven (Drs Brass and Bravata); and Howard Hughes Medical Institute, New Haven (Dr Shulman).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Natural history of blood glucose within the first 48 hours after ischemic stroke
Wong et al.
Neurology 2008;70:1036-1041.
ABSTRACT | FULL TEXT  

Weight Loss After Stroke: A Population-Based Study From the Lund Stroke Register
Jonsson et al.
Stroke 2008;39:918-923.
ABSTRACT | FULL TEXT  

Blood Glucose and Cerebrovascular Disease in Nondiabetic Patients
Nielson and Fleming
ANGIOLOGY 2007;58:625-629.
ABSTRACT  

The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed
Jessani et al.
QJM 2007;100:121-124.
FULL TEXT  

Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients With Transient Ischemic Attack or Minor Ischemic Stroke
Vermeer et al.
Stroke 2006;37:1413-1417.
ABSTRACT | FULL TEXT  

Glucose Tolerance Testing in Patients Scheduled for Cardiovascular Surgery
Hoekstra et al.
SEMIN CARDIOTHORAC VASC ANESTH 2006;10:7-9.
ABSTRACT  

Cost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients
Krinsley and Jones
Chest 2006;129:644-650.
ABSTRACT | FULL TEXT  

Postoperative coma in a patient with complete basilar syndrome after anterior cervical discectomy: [Coma postoperatoire chez un patient atteint d'un syndrome basilaire complet apres une discectomie cervicale anterieure]
Tsai et al.
Canadian J. Anesthesia 2006;53:202-207.
ABSTRACT | FULL TEXT  

Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus
Vancheri et al.
QJM 2005;98:871-878.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.